No. 91-4032

947 F.2d 953
CourtCourt of Appeals for the Tenth Circuit
DecidedOctober 31, 1991
Docket953
StatusPublished

This text of 947 F.2d 953 (No. 91-4032) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
No. 91-4032, 947 F.2d 953 (10th Cir. 1991).

Opinion

947 F.2d 953

NOTICE: Although citation of unpublished opinions remains unfavored, unpublished opinions may now be cited if the opinion has persuasive value on a material issue, and a copy is attached to the citing document or, if cited in oral argument, copies are furnished to the Court and all parties. See General Order of November 29, 1993, suspending 10th Cir. Rule 36.3 until December 31, 1995, or further order.

CARDIOMED, INC., Plaintiff-Appellee,
v.
KARDIOTHOR, INC., Cobe Laboratories, Defendants-Appellants,
and
Does 1 Through 50, Defendants.

No. 91-4032.

United States Court of Appeals, Tenth Circuit.

Oct. 31, 1991.

Before STEPHEN H. ANDERSON, BARRETT and BRORBY, Circuit Judges.

ORDER AND JUDGMENT*

BRORBY, Circuit Judge.

After examining the briefs and appellate record, this panel has determined unanimously that oral argument would not materially assist the determination of this appeal. See Fed.R.App.P. 34(a); 10th Cir.R. 34.1.9. The case is therefore ordered submitted without oral argument.

Defendants appeal the district court's order of February 13, 1991, denying their Motion for Stay of Action Pending Arbitration Proceedings. Defendants moved for a stay pursuant to the Federal Arbitration Act, which requires a federal court, upon application of a party, to stay a suit that is brought on an issue the court concludes is referable to arbitration under a written agreement concerning a transaction involving commerce. 9 U.S.C. §§ 2, 3. Defendants filed a timely notice of appeal from the district court's denial of their motion pursuant to 9 U.S.C. § 16, which permits a party to appeal from the denial of a stay under § 3. We have jurisdiction over this appeal pursuant to 28 U.S.C. § 1292(a). See Peterson v. Shearson/American Express, Inc., 849 F.2d 464, 465 (10th Cir.1988). Based upon our de novo review, Republic of Nicar. v. Standard Fruit Co., 937 F.2d 469, 474 (9th Cir.1991), we reverse.

Plaintiff Cardiomed, Inc. and Defendant Kardiothor, Inc. entered into a License and Distribution Agreement in 1987 pursuant to which Cardiomed was to be the exclusive distributor in four states of a blood recovery and cell-washing system manufactured by Kardiothor. The agreement provided in Article 9 that "[d]isputes arising from the process of termination, that are not determined by this contract, and which are not satisfactorily negotiated by both parties within thirty (30) days of notice of termination, shall be submitted to the American Arbitration Association." Appellants' App. at 23.

In 1988, Cardiomed brought suit alleging that Kardiothor had breached the agreement by various acts, including attempting to terminate the agreement without justification, and that Cobe Laboratories, Kardiothor's successor in interest, had tortiously interfered with the parties' contractual relationship. The suit sought damages, as well as a declaratory judgment that

the language of the agreement upon which Kardiothor claims to rely for unilateral termination of the agreement does not in fact justify termination under the circumstances, but is rather a breach of the agreement by Kardiothor, and further that as such, no right to binding arbitration under Section 9 of the agreement presently exists.

Appellants' App. at 11. Before answering Cardiomed's amended complaint, Kardiothor and Cobe Laboratories filed a motion to stay the proceedings because Cardiomed's claim for declaratory relief concerned a subject that the parties had agreed to submit to arbitration under Article 9 of the agreement. The district court denied the motion without stating its reasons for doing so.

Our analysis of this appeal is guided by three general principles. First, although the distribution agreement provides that it is to be governed by Texas law, whether the parties' dispute is arbitrable is determined by federal law. Mitsubishi Motors Corp. v. Soler Chrysler-Plymouth, Inc., 473 U.S. 614, 626 (1985); see also Merrill Lynch, Pierce, Fenner & Smith, Inc. v. DeCaro, 577 F.Supp. 616, 619 (W.D.Mo.1983). Second, "the court's role is limited to determining whether the parties submitted the 'subject matter' of a particular dispute to arbitration." Denhardt v. Trailways, Inc., 767 F.2d 687, 690 (10th Cir.1985). Third, "[t]here is a strong federal policy favoring arbitration for dispute resolution." Peterson, 849 F.2d at 465. Accordingly, all "doubts are to be resolved in favor of arbitrability." Oil, Chem. & Atomic Workers Int'l Union, Local 2-124 v. American Oil Co., 528 F.2d 252, 254 (10th Cir.1976).

Pursuant to the arbitration clause at issue here, a dispute must (1) arise from the process of termination, (2) not be determined by the agreement, and (3) not be satisfactorily negotiated by the parties within thirty days of notice of termination, to be arbitrable. In support of the district court's order denying stay, Cardiomed advances arguments based on each of these three conditions.

First, Cardiomed argues that because the distribution agreement did not permit Kardiothor to terminate it on the ground allegedly advanced by Kardiothor--that Kardiothor had been acquired by Cobe Laboratories--Kardiothor's attempt to terminate the agreement was a breach of the agreement, not a termination thereof, so the dispute between the parties did not arise from the process of termination. This argument is circular, and we reject it. Cardiomed's claim for declaratory relief disputes Kardiothor's right to terminate the agreement. Such a dispute necessarily arises from the process of termination.

Second, Cardiomed argues that even if Kardiothor attempted to terminate the agreement because Cardiomed breached its obligation to perform, the propriety of that termination would not be arbitrable because the agreement determines Cardiomed's obligations to perform. In deciding whether an issue is arbitrable, we must accept the facts as advanced by the party seeking arbitration. See Shanferoke Coal & Supply Corp. v. Westchester Serv. Corp., 70 F.2d 297, 299 (2d Cir.1934), aff'd, 293 U.S. 449 (1935). Kardiothor contends that one of the reasons it terminated the agreement is that Cardiomed failed to "use its best efforts to develop and exploit the markets and to sell the System in the Exclusive Territory," as required by Article 2.5 of the agreement. Appellants' App. at 16.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
947 F.2d 953, Counsel Stack Legal Research, https://law.counselstack.com/opinion/no-91-4032-ca10-1991.